-   directed: true
    graph:
        drug: Tegafur
        drugbank: DB:DB09256
        drug_mesh: MESH:D005641
        disease: Malignant tumor of stomach
        disease_mesh: MESH:D013274
    links:
    -   key: increases activity of
        source: MESH:D005641
        target: InterPro:IPR001128
    -   key: increases abundance of
        source: InterPro:IPR001128
        target: MESH:D005472
    -   key: has metabolite
        source: MESH:D005472
        target: MESH:D005468
    -   key: has metabolite
        source: MESH:D005472
        target: MESH:C025635
    -   key: negatively regulates
        source: MESH:C025635
        target: GO:0032774
    -   key: negatively regulates
        source: MESH:C025635
        target: GO:0006412
    -   key: decreases activity of
        source: MESH:D005468
        target: UniProt:P04818
    -   key: negatively regulates
        source: UniProt:P04818
        target: GO:0071897
    -   key: located in
        source: GO:0071897
        target: CL:0001063
    -   key: located in
        source: GO:0032774
        target: CL:0001063
    -   key: located in
        source: GO:0006412
        target: CL:0001063
    -   key: contributes to
        source: CL:0001063
        target: MESH:D013274
    multigraph: true
    nodes:
    -   id: MESH:D005641
        label: Drug
        name: Tegafur
    -   id: InterPro:IPR001128
        label: GeneFamily
        name: cytochrome P-450
    -   id: MESH:D005472
        label: ChemicalSubstance
        name: 5-fluorouracil
    -   id: MESH:D005468
        label: ChemicalSubstance
        name: 5-fluoro-2-deoxyuridine monophosphate
    -   id: MESH:C025635
        label: ChemicalSubstance
        name: 5-fluorouridine triphosphate
    -   id: UniProt:P04818
        label: Protein
        name: Thymidylate synthase
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA synthesis
    -   id: GO:0032774
        label: BiologicalProcess
        name: RNA synthesis
    -   id: GO:0006412
        label: BiologicalProcess
        name: Protein synthesis
    -   id: CL:0001063
        label: Cell
        name: tumor cell
    -   id: MESH:D013274
        label: Disease
        name: Malignant tumor of stomach
    reference: https://go.drugbank.com/drugs/DB09256#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Tegafur#section=Mechanism-of-Action
-   directed: true
    graph:
        drug: Paliperidone
        drugbank: DB:DB01267
        drug_mesh: NULL
        disease: Schizophrenia
        disease_mesh: MESH:D012559
    links:
    -   key: decreases activity of
        source: DB:DB01267
        target: UniProt:P35348
    -   key: positively regulates
        source: UniProt:P35348
        target: REACT:R-HSA-162582
    -   key: decreases activity of
        source: DB:DB01267
        target: UniProt:P08913
    -   key: positively regulates
        source: UniProt:P08913
        target: REACT:R-HSA-162582
    -   key: decreases activity of
        source: DB:DB01267
        target: UniProt:P35367
    -   key: positively regulates
        source: UniProt:P35367
        target: REACT:R-HSA-162582
    -   key: decreases activity of
        source: DB:DB01267
        target: UniProt:P28223
    -   key: positively regulates
        source: UniProt:P28223
        target: REACT:R-HSA-162582
    -   key: decreases activity of
        source: DB:DB01267
        target: UniProt:P14416
    -   key: positively regulates
        source: UniProt:P14416
        target: REACT:R-HSA-162582
    -   key: correlated with
        source: REACT:R-HSA-162582
        target: MESH:D012559
    multigraph: true
    nodes:
    -   id: DB:DB01267
        label: Drug
        name: Paliperidone
    -   id: UniProt:P35348
        label: Protein
        name: Alpha 1 adrenergic receptor
    -   id: UniProt:P08913
        label: Protein
        name: Alpha 2 adrenergic receptor
    -   id: UniProt:P35367
        label: Protein
        name: Histamine H1 receptor
    -   id: UniProt:P28223
        label: Protein
        name: 5-hydroxytryptamine receptor 2A
    -   id: UniProt:P14416
        label: Protein
        name: D(2) dopamine receptor
    -   id: REACT:R-HSA-162582
        label: Pathway
        name: Signal transduction
    -   id: MESH:D012559
        label: Disease
        name: Schizophrenia
    reference: https://go.drugbank.com/drugs/DB01267#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Paliperidone
-   directed: true
    graph:
        drug: Tandospirone
        drugbank: DB:DB12833
        drug_mesh: MESH:C055267
        disease: Bruxism (teeth grinding)
        disease_mesh: MESH:D002012
    links:
    -   key: increases activity of
        source: MESH:C055267
        target: UniProt:P08908
    -   key: negatively regulates
        source: UniProt:P08908
        target: HP:0000739
    -   key: correlated with
        source: HP:0000739
        target: MESH:D002012
    multigraph: true
    nodes:
    -   id: MESH:C055267
        label: Drug
        name: Tandospirone
    -   id: UniProt:P08908
        label: Protein
        name: 5-HT1A receptor
    -   id: HP:0000739
        label: PhenotypicFeature
        name: Anxiety
    -   id: MESH:D002012
        label: Disease
        name: Bruxism
    reference: https://go.drugbank.com/drugs/DB12833#mechanismofaction
-   directed: true
    graph:
        drug: Nintedanib
        drugbank: DB:DB09079
        drug_mesh: MESH:C530716
        disease: Non-small cell lung cancer
        disease_mesh: MESH:D002289
    links:
    -   key: decreases activity of
        source: MESH:C530716
        target: InterPro:IPR009135
    -   key: negatively regulates
        source: InterPro:IPR009135
        target: REACT:R-HSA-194138
    -   key: participates in
        source: REACT:R-HSA-194138
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:C530716
        target: InterPro:IPR016248
    -   key: negatively regulates
        source: InterPro:IPR016248
        target: REACT:R-HSA-190236
    -   key: participates in
        source: REACT:R-HSA-190236
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:C530716
        target: InterPro:IPR006782
    -   key: negatively regulates
        source: InterPro:IPR006782
        target: REACT:R-HSA-186797
    -   key: participates in
        source: REACT:R-HSA-186797
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:C530716
        target: UniProt:P36888
    -   key: negatively regulates
        source: UniProt:P36888
        target: REACT:R-HSA-9607240
    -   key: participates in
        source: REACT:R-HSA-9607240
        target: GO:0001525
    -   key: prevents
        source: GO:0001525
        target: GO:0008283
    -   key: contributes to
        source: GO:0008283
        target: MESH:D002289
    multigraph: true
    nodes:
    -   id: MESH:C530716
        label: Drug
        name: Nintedanib
    -   id: InterPro:IPR009135
        label: GeneFamily
        name: Vascular endothelial growth factor receptor
    -   id: REACT:R-HSA-194138
        label: Pathway
        name: Signaling by VEGF
    -   id: UniProt:P36888
        label: Protein
        name: fms like tyrosine kinase 3 (FLT-3)
    -   id: REACT:R-HSA-9607240
        label: Pathway
        name: FLT3 Signaling
    -   id: InterPro:IPR006782
        label: GeneFamily
        name: Platelet-derived growth factor receptor
    -   id: REACT:R-HSA-186797
        label: Pathway
        name: Signaling by PDGF
    -   id: InterPro:IPR016248
        label: GeneFamily
        name: Fibroblast growth factor receptor
    -   id: REACT:R-HSA-190236
        label: Pathway
        name: Signaling by FGFR
    -   id: GO:0001525
        label: BiologicalProcess
        name: Angiogenesis
    -   id: GO:0008283
        label: BiologicalProcess
        name: Cell proliferation
    -   id: MESH:D002289
        label: Disease
        name: Non-small cell lung cancer
    reference: https://go.drugbank.com/drugs/DB09079#mechanismofaction https://en.wikipedia.org/wiki/Nintedanib doi:10.1183/09031936.00174914
-   directed: true
    graph:
        drug: Nintedanib
        drugbank: DB:DB09079
        drug_mesh: MESH:C530716
        disease: Hamman-Rich syndrome
        disease_mesh: MESH:D000080203
    links:
    -   key: decreases activity of
        source: MESH:C530716
        target: UniProt:P12931
    -   key: negatively regulates
        source: UniProt:P12931
        target: REACT:R-HSA-9006927
    -   key: decreases activity of
        source: MESH:C530716
        target: UniProt:P06239
    -   key: negatively regulates
        source: UniProt:P06239
        target: REACT:R-HSA-9006927
    -   key: decreases activity of
        source: MESH:C530716
        target: UniProt:P07948
    -   key: negatively regulates
        source: UniProt:P07948
        target: REACT:R-HSA-9006927
    -   key: prevents
        source: REACT:R-HSA-9006927
        target: HP:0006530
    -   key: correlated with
        source: HP:0006530
        target: MESH:D000080203
    multigraph: true
    nodes:
    -   id: MESH:C530716
        label: Drug
        name: Nintedanib
    -   id: UniProt:P12931
        label: Protein
        name: Proto-oncogene tyrosine-protein kinase Src
    -   id: UniProt:P07948
        label: Protein
        name: Tyrosine-protein kinase Lyn
    -   id: UniProt:P06239
        label: Protein
        name: Tyrosine-protein kinase Lck
    -   id: REACT:R-HSA-9006927
        label: Pathway
        name: Signaling by Non-Receptor Tyrosine Kinases
    -   id: HP:0006530
        label: PhenotypicFeature
        name: lung fibrosis
    -   id: MESH:D000080203
        label: Disease
        name: Hamman-Rich syndrome
    reference: https://go.drugbank.com/drugs/DB09079#mechanismofaction https://en.wikipedia.org/wiki/Nintedanib doi:10.1183/09031936.00174914
-   directed: true
    graph:
        drug: Obiltoxaximab
        drugbank: DB:DB05336
        drug_mesh: MESH:C000611266
        disease: Inhalational anthrax
        disease_mesh: MESH:C571912
    links:
    -   key: molecularly interacts with
        source: MESH:C000611266
        target: InterPro:IPR027439
    -   key: part of
        source: InterPro:IPR027439
        target: MESH:C030325
    -   key: prevents
        source: MESH:C030325
        target: GO:0035635
    -   key: in taxon
        source: GO:0035635
        target: NCBITaxon:1392
    -   key: causes
        source: NCBITaxon:1392
        target: MESH:C571912
    multigraph: true
    nodes:
    -   id: MESH:C000611266
        label: Drug
        name: Obiltoxaximab
    -   id: InterPro:IPR027439
        label: GeneFamily
        name: Protective Antigen
    -   id: MESH:C030325
        label: ChemicalSubstance
        name: Anthrax toxin
    -   id: GO:0035635
        label: BiologicalProcess
        name: Entry of bacterium into host cell
    -   id: NCBITaxon:1392
        label: OrganismTaxon
        name: Bacillus anthracis
    -   id: MESH:C571912
        label: Disease
        name: Inhalational anthrax
    reference: https://go.drugbank.com/drugs/DB05336#mechanismofaction
-   directed: true
    graph:
        drug: Lusutrombopag
        drugbank: DB:DB13125
        drug_mesh: MESH:C000611387
        disease: Thrombocytopenic disorder
        disease_mesh: MESH:D013921
    links:
    -   key: increases activity of
        source: MESH:C000611387
        target: UniProt:P40238
    -   key: positively regulates
        source: UniProt:P40238
        target: GO:0007259
    -   key: enables
        source: GO:0007259
        target: MESH:D034061
    -   key: expressed in
        source: MESH:D034061
        target: CL:0000556
    -   key: increases activity of
        source: CL:0000556
        target: GO:0008283
    -   key: increases abundance of
        source: GO:0008283
        target: HP:0001873
    -   key: increases activity of
        source: CL:0000556
        target: GO:0030154
    -   key: increases abundance of
        source: GO:0030154
        target: HP:0001873
    -   key: manifestation of
        source: HP:0001873
        target: MESH:D013921
    multigraph: true
    nodes:
    -   id: MESH:C000611387
        label: Drug
        name: Lusutrombopag
    -   id: UniProt:P40238
        label: Protein
        name: thrombopoietin receptor
    -   id: GO:0007259
        label: BiologicalProcess
        name: Receptor signaling pathway via JAK-STAT
    -   id: MESH:D034061
        label: BiologicalProcess
        name: Thrombocytopoiesis
    -   id: CL:0000556
        label: Cell
        name: Megakaryocytes
    -   id: GO:0008283
        label: BiologicalProcess
        name: Cell population proliferation
    -   id: GO:0030154
        label: BiologicalProcess
        name: Cell differentiation
    -   id: HP:0001873
        label: PhenotypicFeature
        name: Platelet counts
    -   id: MESH:D013921
        label: Disease
        name: Thrombocytopenic disorder
    reference: https://go.drugbank.com/drugs/DB13125#mechanismofaction
-   directed: true
    graph:
        drug: Lucinactant
        drugbank: DB:DB04897
        drug_mesh: MESH:C502722
        disease: Respiratory distress syndrome in the newborn
        disease_mesh: MESH:D012127
    links:
    -   key: chemically similar to
        source: MESH:C502722
        target: UniProt:P07988
    -   key: decreases activity of
        source: UniProt:P07988
        target: GO:0050828
    -   key: located in
        source: GO:0050828
        target: UBERON:0002299
    -   key: increases activity of
        source: UBERON:0002299
        target: GO:0043576
    -   key: correlated with
        source: GO:0043576
        target: MESH:D012127
    multigraph: true
    nodes:
    -   id: MESH:C502722
        label: Drug
        name: Lucinactant
    -   id: UniProt:P07988
        label: Protein
        name: Surfactant protein B (SP-B)
    -   id: GO:0050828
        label: BiologicalProcess
        name: Surface tension at the air-liquid interface
    -   id: UBERON:0002299
        label: GrossAnatomicalStructure
        name: Alveolus of lung
    -   id: GO:0043576
        label: BiologicalProcess
        name: Respiratory gaseous exchange
    -   id: MESH:D012127
        label: Disease
        name: Respiratory distress syndrome in the newborn
    reference: https://go.drugbank.com/drugs/DB04897#mechanismofaction
-   directed: true
    graph:
        drug: Levocabastine
        drugbank: DB:DB01106
        drug_mesh: MESH:C047340
        disease: Allergic conjunctivitis
        disease_mesh: MESH:D003233
    links:
    -   key: decreases activity of
        source: MESH:C047340
        target: UniProt:P35367
    -   key: prevents
        source: UniProt:P35367
        target: GO:0051381
    -   key: decreases response to
        source: GO:0051381
        target: HP:0000989
    -   key: manifestation of
        source: HP:0000989
        target: MESH:D003233
    multigraph: true
    nodes:
    -   id: MESH:C047340
        label: Drug
        name: Levocabastine
    -   id: UniProt:P35367
        label: Protein
        name: Histamine H1-receptor
    -   id: GO:0051381
        label: BiologicalProcess
        name: Histamine binding
    -   id: HP:0000989
        label: PhenotypicFeature
        name: Itching
    -   id: MESH:D003233
        label: Disease
        name: Allergic conjunctivitis
    reference: https://go.drugbank.com/drugs/DB01106#mechanismofaction
-   directed: true
    graph:
        drug: Levocabastine
        drugbank: DB:DB01106
        drug_mesh: MESH:C047340
        disease: Allergic conjunctivitis
        disease_mesh: MESH:D003233
    links:
    -   key: increases activity of
        source: MESH:C047340
        target: UniProt:O95665
    -   key: decreases response to
        source: UniProt:O95665
        target: HP:0012531
    -   key: correlated with
        source: HP:0012531
        target: MESH:D003233
    multigraph: true
    nodes:
    -   id: MESH:C047340
        label: Drug
        name: Levocabastine
    -   id: UniProt:O95665
        label: Protein
        name: Neurotensin receptor type 2
    -   id: HP:0012531
        label: PhenotypicFeature
        name: Pain
    -   id: MESH:D003233
        label: Disease
        name: Allergic conjunctivitis
    reference: https://go.drugbank.com/drugs/DB01106#mechanismofaction
-   directed: true
    graph:
        drug: Ethosuximide
        drugbank: DB:DB00593
        drug_mesh: MESH:D005013
        disease: Absence seizure
        disease_mesh: MESH:D004832
    links:
    -   key: positively regulates
        source: MESH:D005013
        target: UniProt:O43497
    -   key: increases transport of
        source: UniProt:O43497
        target: MESH:D002118
    -   key: decreases activity of
        source: MESH:D002118
        target: GO:0099608
    -   key: located in
        source: GO:0099608
        target: UBERON:0000955
    -   key: prevents
        source: UBERON:0000955
        target: MESH:D004832
    multigraph: true
    nodes:
    -   id: MESH:D005013
        label: Drug
        name: Ethosuximide
    -   id: UniProt:O43497
        label: Protein
        name: T-type voltage sensitive calcium channels
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium ions
    -   id: GO:0099608
        label: BiologicalProcess
        name: Regulation of action potential firing pattern
    -   id: UBERON:0000955
        label: GrossAnatomicalStructure
        name: Brain
    -   id: MESH:D004832
        label: Disease
        name: Absence seizure
    reference: https://go.drugbank.com/drugs/DB00593#mechanismofaction doi:10.1111/j.1527-3458.2007.00009.x https://pubchem.ncbi.nlm.nih.gov/compound/Ethosuximide#section=Pharmacology-and-Biochemistry
-   directed: true
    graph:
        drug: Ethosuximide
        drugbank: DB:DB00593
        drug_mesh: MESH:D005013
        disease: Absence seizure
        disease_mesh: MESH:D004832
    links:
    -   key: decreases activity of
        source: MESH:D005013
        target: GO:0005228
    -   key: increases transport of
        source: GO:0005228
        target: MESH:D009569
    -   key: decreases activity of
        source: MESH:D005013
        target: GO:0015269
    -   key: increases transport of
        source: GO:0015269
        target: MESH:D009569
    -   key: positively regulates
        source: MESH:D009569
        target: GO:0042747
    -   key: prevents
        source: GO:0042747
        target: MESH:D004832
    multigraph: true
    nodes:
    -   id: MESH:D005013
        label: Drug
        name: Ethosuximide
    -   id: GO:0005228
        label: MolecularActivity
        name: Intracellular sodium activated potassium channel activity
    -   id: GO:0015269
        label: MolecularActivity
        name: Calcium-activated potassium channel activity
    -   id: MESH:D009569
        label: ChemicalSubstance
        name: Nitric oxide
    -   id: GO:0042747
        label: BiologicalProcess
        name: Paradoxical sleep
    -   id: MESH:D004832
        label: Disease
        name: Absence seizure
    reference: https://go.drugbank.com/drugs/DB00593#mechanismofaction doi:10.1111/j.1527-3458.2007.00009.x https://pubchem.ncbi.nlm.nih.gov/compound/Ethosuximide#section=Pharmacology-and-Biochemistry
-   directed: true
    comment: Empagliflozin is used in combination with proper diet and exercise
    graph:
        drug: Empagliflozin
        drugbank: DB:DB09038
        drug_mesh: MESH:C570240
        disease: Diabetes mellitus type 2
        disease_mesh: MESH:D003924
    links:
    -   key: decreases activity of
        source: MESH:C570240
        target: UniProt:P31639
    -   key: negatively regulates
        source: UniProt:P31639
        target: GO:0035623
    -   key: causes
        source: GO:0035623
        target: HP:0003076
    -   key: decreases abundance of
        source: HP:0003076
        target: MESH:D001786
    -   key: correlated with
        source: MESH:D001786
        target: MESH:D003924
    multigraph: true
    nodes:
    -   id: MESH:C570240
        label: Drug
        name: Empagliflozin
    -   id: UniProt:P31639
        label: Protein
        name: Sodium/glucose cotransporter 2
    -   id: GO:0035623
        label: BiologicalProcess
        name: Renal glucose absorption
    -   id: HP:0003076
        label: PhenotypicFeature
        name: Glycosuria
    -   id: MESH:D001786
        label: ChemicalSubstance
        name: Blood Glucose
    -   id: MESH:D003924
        label: Disease
        name: Diabetes mellitus type 2
    reference: https://go.drugbank.com/drugs/DB09038#mechanismofaction
-   directed: true
    graph:
        drug: Cimetidine
        drugbank: DB:DB00501
        drug_mesh: MESH:D002927
        disease: Duodenal ulcer disease
        disease_mesh: MESH:D004381
    links:
    -   key: decreases activity of
        source: MESH:D002927
        target: UniProt:P25021
    -   key: prevents
        source: UniProt:P25021
        target: GO:0051381
    -   key: negatively regulates
        source: GO:0051381
        target: GO:0001696
    -   key: contributes to
        source: GO:0001696
        target: MESH:D004381
    multigraph: true
    nodes:
    -   id: MESH:D002927
        label: Drug
        name: Cimetidine
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0051381
        label: BiologicalProcess
        name: Histamine binding
    -   id: GO:0001696
        label: BiologicalProcess
        name: Gastric acid secretion
    -   id: MESH:D004381
        label: Disease
        name: Duodenal ulcer disease
    reference: https://go.drugbank.com/drugs/DB00501#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology
-   directed: true
    graph:
        drug: Cimetidine
        drugbank: DB:DB00501
        drug_mesh: MESH:D002927
        disease: Gastric ulcer
        disease_mesh: MESH:D013276
    links:
    -   key: decreases activity of
        source: MESH:D002927
        target: UniProt:P25021
    -   key: prevents
        source: UniProt:P25021
        target: GO:0051381
    -   key: negatively regulates
        source: GO:0051381
        target: GO:0001696
    -   key: contributes to
        source: GO:0001696
        target: MESH:D013276
    multigraph: true
    nodes:
    -   id: MESH:D002927
        label: Drug
        name: Cimetidine
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0051381
        label: BiologicalProcess
        name: Histamine binding
    -   id: GO:0001696
        label: BiologicalProcess
        name: Gastric acid secretion
    -   id: MESH:D013276
        label: Disease
        name: Gastric ulcer
    reference: https://go.drugbank.com/drugs/DB00501#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology
-   directed: true
    graph:
        drug: Cimetidine
        drugbank: DB:DB00501
        drug_mesh: MESH:D002927
        disease: Zollinger-Ellison syndrome
        disease_mesh: MESH:D015043
    links:
    -   key: decreases activity of
        source: MESH:D002927
        target: UniProt:P25021
    -   key: prevents
        source: UniProt:P25021
        target: GO:0034776
    -   key: negatively regulates
        source: GO:0034776
        target: InterPro:IPR000072
    -   key: correlated with
        source: InterPro:IPR000072
        target: MESH:D015043
    multigraph: true
    nodes:
    -   id: MESH:D002927
        label: Drug
        name: Cimetidine
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0034776
        label: BiologicalProcess
        name: Response to histamine
    -   id: InterPro:IPR000072
        label: GeneFamily
        name: Vascular endothelial growth factor (VEGF)
    -   id: MESH:D015043
        label: Disease
        name: Zollinger-Ellison syndrome
    reference: https://go.drugbank.com/drugs/DB00501#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology
-   directed: true
    graph:
        drug: Cimetidine
        drugbank: DB:DB00501
        drug_mesh: MESH:D002927
        disease: Multiple endocrine adenomas
        disease_mesh: MESH:D009377
    links:
    -   key: decreases activity of
        source: MESH:D002927
        target: UniProt:P25021
    -   key: prevents
        source: UniProt:P25021
        target: GO:0034776
    -   key: negatively regulates
        source: GO:0034776
        target: InterPro:IPR000072
    -   key: correlated with
        source: InterPro:IPR000072
        target: MESH:D009377
    multigraph: true
    nodes:
    -   id: MESH:D002927
        label: Drug
        name: Cimetidine
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0034776
        label: BiologicalProcess
        name: Response to histamine
    -   id: InterPro:IPR000072
        label: GeneFamily
        name: Vascular endothelial growth factor (VEGF)
    -   id: MESH:D009377
        label: Disease
        name: Multiple endocrine adenomas
    reference: https://go.drugbank.com/drugs/DB00501#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology
-   directed: true
    graph:
        drug: Cimetidine
        drugbank: DB:DB00501
        drug_mesh: MESH:D002927
        disease: Indigestion
        disease_mesh: MESH:D004415
    links:
    -   key: decreases activity of
        source: MESH:D002927
        target: UniProt:P25021
    -   key: prevents
        source: UniProt:P25021
        target: GO:0051381
    -   key: negatively regulates
        source: GO:0051381
        target: GO:0001696
    -   key: contributes to
        source: GO:0001696
        target: MESH:D004415
    multigraph: true
    nodes:
    -   id: MESH:D002927
        label: Drug
        name: Cimetidine
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0051381
        label: BiologicalProcess
        name: Histamine binding
    -   id: GO:0001696
        label: BiologicalProcess
        name: Gastric acid secretion
    -   id: MESH:D004415
        label: Disease
        name: Indigestion
    reference: https://go.drugbank.com/drugs/DB00501#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology
-   directed: true
    graph:
        drug: Cimetidine
        drugbank: DB:DB00501
        drug_mesh: MESH:D002927
        disease: Gastroesophageal reflux disease
        disease_mesh: MESH:D005764
    links:
    -   key: decreases activity of
        source: MESH:D002927
        target: UniProt:P25021
    -   key: prevents
        source: UniProt:P25021
        target: GO:0051381
    -   key: negatively regulates
        source: GO:0051381
        target: GO:0001696
    -   key: contributes to
        source: GO:0001696
        target: MESH:D005764
    multigraph: true
    nodes:
    -   id: MESH:D002927
        label: Drug
        name: Cimetidine
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0051381
        label: BiologicalProcess
        name: Histamine binding
    -   id: GO:0001696
        label: BiologicalProcess
        name: Gastric acid secretion
    -   id: MESH:D005764
        label: Disease
        name: Gastroesophageal reflux disease
    reference: https://go.drugbank.com/drugs/DB00501#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology
-   directed: true
    graph:
        drug: Cimetidine
        drugbank: DB:DB00501
        drug_mesh: MESH:D002927
        disease: Heartburn
        disease_mesh: MESH:D006356
    links:
    -   key: decreases activity of
        source: MESH:D002927
        target: UniProt:P25021
    -   key: prevents
        source: UniProt:P25021
        target: GO:0051381
    -   key: negatively regulates
        source: GO:0051381
        target: GO:0001696
    -   key: contributes to
        source: GO:0001696
        target: MESH:D006356
    multigraph: true
    nodes:
    -   id: MESH:D002927
        label: Drug
        name: Cimetidine
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0051381
        label: BiologicalProcess
        name: Histamine binding
    -   id: GO:0001696
        label: BiologicalProcess
        name: Gastric acid secretion
    -   id: MESH:D006356
        label: Disease
        name: Heartburn
    reference: https://go.drugbank.com/drugs/DB00501#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology
-   directed: true
    comment: Cimetidine has a role in treating the symptoms of systemic mastocytosis
    graph:
        drug: Cimetidine
        drugbank: DB:DB00501
        drug_mesh: MESH:D002927
        disease: Systemic mast cell disease
        disease_mesh: MESH:D034721
    links:
    -   key: decreases activity of
        source: MESH:D002927
        target: UniProt:P25021
    -   key: prevents
        source: UniProt:P25021
        target: GO:0001821
    -   key: located in
        source: GO:0001821
        target: CL:0000097
    -   key: correlated with
        source: CL:0000097
        target: MESH:D034721
    multigraph: true
    nodes:
    -   id: MESH:D002927
        label: Drug
        name: Cimetidine
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0001821
        label: BiologicalProcess
        name: Histamine secretion
    -   id: CL:0000097
        label: Cell
        name: Mast cell
    -   id: MESH:D034721
        label: Disease
        name: Systemic mast cell disease
    reference: https://go.drugbank.com/drugs/DB00501#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology
-   directed: true
    graph:
        drug: Naloxone
        drugbank: DB:DB01183
        drug_mesh: MESH:D009270
        disease: Opioid dependence
        disease_mesh: MESH:D009293
    links:
    -   key: decreases activity of
        source: MESH:D009270
        target: UniProt:P41143
    -   key: negatively regulates
        source: UniProt:P41143
        target: InterPro:IPR000276   
    -   key: decreases activity of
        source: MESH:D009270
        target: UniProt:P35372
    -   key: negatively regulates
        source: UniProt:P35372
        target: InterPro:IPR000276
    -   key: decreases activity of
        source: MESH:D009270
        target: UniProt:P41145
    -   key: negatively regulates
        source: UniProt:P41145
        target: InterPro:IPR000276
    -   key: decreases activity of
        source: InterPro:IPR000276
        target: InterPro:IPR000274
    -   key: decreases abundance of
        source: InterPro:IPR000274
        target: MESH:D000242
    -   key: causes
        source: MESH:D000242
        target: MESH:D013375
    -   key: correlated with
        source: MESH:D013375
        target: MESH:D009293
    multigraph: true
    nodes:
    -   id: MESH:D009270
        label: Drug
        name: Naloxone
    -   id: UniProt:P35372
        label: Protein
        name: Mu-type opioid receptor
    -   id: UniProt:P41143
        label: Protein
        name: Delta-type opioid receptor
    -   id: UniProt:P41145
        label: Protein
        name: Kappa-type opioid receptor
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G-Protein coupled receptor
    -   id: InterPro:IPR000274
        label: GeneFamily
        name: Adenylate cyclase
    -   id: MESH:D000242
        label: ChemicalSubstance
        name: cAMP levels
    -   id: MESH:D013375
        label: Disease
        name: Withdrawal symptoms
    -   id: MESH:D009293
        label: Disease
        name: Opioid dependence
    reference: https://go.drugbank.com/drugs/DB01183#mechanismofaction DOI:10.18773/austprescr/1996.063 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999180/
-   directed: true
    graph:
        drug: Naloxone
        drugbank: DB:DB01183
        drug_mesh: MESH:D009270
        disease: Pain
        disease_mesh: MESH:D010146
    links:
    -   key: decreases activity of
        source: MESH:D009270
        target: UniProt:P41143
    -   key: negatively regulates
        source: UniProt:P41143
        target: InterPro:IPR000276   
    -   key: decreases activity of
        source: MESH:D009270
        target: UniProt:P35372
    -   key: negatively regulates
        source: UniProt:P35372
        target: InterPro:IPR000276
    -   key: decreases activity of
        source: MESH:D009270
        target: UniProt:P41145
    -   key: negatively regulates
        source: UniProt:P41145
        target: InterPro:IPR000276
    -   key: decreases activity of
        source: InterPro:IPR000276
        target: InterPro:IPR000274
    -   key: decreases abundance of
        source: InterPro:IPR000274
        target: MESH:D000242
    -   key: positively regulates
        source: MESH:D000242
        target: GO:0048265
    -   key: caused by
        source: GO:0048265
        target: MESH:D010146
    multigraph: true
    nodes:
    -   id: MESH:D009270
        label: Drug
        name: Naloxone
    -   id: UniProt:P35372
        label: Protein
        name: Mu-type opioid receptor
    -   id: UniProt:P41143
        label: Protein
        name: Delta-type opioid receptor
    -   id: UniProt:P41145
        label: Protein
        name: Kappa-type opioid receptor
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G-Protein coupled receptor
    -   id: InterPro:IPR000274
        label: GeneFamily
        name: Adenylate cyclase
    -   id: MESH:D000242
        label: ChemicalSubstance
        name: cAMP levels
    -   id: GO:0048265
        label: BiologicalProcess
        name: Response to pain
    -   id: MESH:D010146
        label: Disease
        name: Pain
    reference: https://go.drugbank.com/drugs/DB01183#mechanismofaction DOI:10.18773/austprescr/1996.063 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999180/

